Preparation of the patient for PCI
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [4]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [5] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
History
Physical
Laboratory Examination
2011 ACCF/AHA Guidelines from Bleeding Risk[1] (DO NOT EDIT)
| Class I |
|
"1. All patients should be evaluated for risk of bleeding before PCI. (Level of Evidence: C)" |
Imaging Studies
The Electrocardiogram
2011 ACCF/AHA Guidelines for Heart Team Approach to Revascularization Decisions[1] (DO NOT EDIT)
| Class I |
|
"1. A Heart Team approach to revascularization is recommended in patients with unprotected left main or complex CAD. [2][3][4] (Level of Evidence: C)" |
| Class IIa |
|
"1. Calculation of the Society of Thoracic Surgeons and SYNTAX (Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery) scores is reasonable in patients with unprotected left main and complex CAD. [4][5][6][7][8][9][10][11] (Level of Evidence: B)" |
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions: Guidelines for Percutaneous Hemodynamic Support Devices (DO NOT EDIT)
| Class IIb |
| "1. Elective insertion of an appropriate hemodynamic support device as an adjunct to PCI may be reasonable in carefully selected high-risk patients. (Level of Evidence: C)" |
2011 ACCF/AHA Guidelines for Role of Onsite Surgical Backup[1] (DO NOT EDIT)
| Class III (Harm) |
|
"1. Primary or elective PCI should not be performed in hospitals without on-site cardiac surgery capabilities without a proven plan for rapid transport to a cardiac surgery operating room in a nearby hospital or without appropriate hemodynamic support capability for transfer. (Level of Evidence: C)" |
| Class IIa |
|
"1. Primary PCI is reasonable in hospitals without on-site cardiac surgery, provided that appropriate planning for program development has been accomplished.[12][13] (Level of Evidence: B)" |
| Class IIb |
|
"1. Elective PCI might be considered in hospitals without on-site cardiac surgery, provided that appropriate planning for program development has been accomplished and rigorous clinical and angiographic criteria are used for proper patient selection.[13][14][15] (Level of Evidence: B)" |
Premedications
Hydration
References
- ↑ 1.0 1.1 1.2 Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH (2011). "2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions" (PDF). Journal of the American College of Cardiology. 58 (24): 2550–83. doi:10.1016/j.jacc.2011.08.006. PMID 22070837. Retrieved 2011-12-08. Text "PDF" ignored (help); Unknown parameter
|month=ignored (help) - ↑ Feit F, Brooks MM, Sopko G, Keller NM, Rosen A, Krone R et al. (2000)Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: comparison with the randomized trial. BARI Investigators. Circulation 101 (24):2795-802. PMID: [1]
- ↑ King SB, Barnhart HX, Kosinski AS, Weintraub WS, Lembo NJ, Petersen JY et al. (1997) Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators.Am J Cardiol 79 (11):1453-9. PMID: 9185632
- ↑ 4.0 4.1 Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ et al. (2009)Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360 (10):961-72. DOI:10.1056/NEJMoa0804626 PMID:19228612
- ↑ Chakravarty T, Buch MH, Naik H, White AJ, Doctor N, Schapira J et al. (2011) Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization. Am J Cardiol 107 (3):360-6. DOI:10.1016/j.amjcard.2010.09.029 PMID:21256999
- ↑ Grover FL, Shroyer AL, Hammermeister K, Edwards FH, Ferguson TB, Dziuban SW et al. (2001)A decade's experience with quality improvement in cardiac surgery using the Veterans Affairs and Society of Thoracic Surgeons national databases.Ann Surg 234 (4):464-72; discussion 472-4. PMID: 11573040
- ↑ Kim YH, Park DW, Kim WJ, Lee JY, Yun SC, Kang SJ et al. (2010)Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization. JACC Cardiovasc Interv 3 (6):612-23.DOI:10.1016/j.jcin.2010.04.004 PMID:20630454
- ↑ Morice MC, Serruys PW, Kappetein AP, Feldman TE, Ståhle E, Colombo A et al. (2010)Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 121 (24):2645-53.DOI:10.1161/CIRCULATIONAHA.109.899211 PMID:20530001
- ↑ Shahian DM, O'Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB et al. (2009)The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg 88 (1 Suppl):S2-22. [2] PMID: 19559822
- ↑ Shahian DM, O'Brien SM, Normand SL, Peterson ED, Edwards FH (2010)Association of hospital coronary artery bypass volume with processes of care, mortality, morbidity, and the Society of Thoracic Surgeons composite quality score. J Thorac Cardiovasc Surg 139 (2):273-82.DOI:10.1016/j.jtcvs.2009.09.007 PMID:20022608
- ↑ Welke KF, Peterson ED, Vaughan-Sarrazin MS, O'Brien SM, Rosenthal GE, Shook GJ et al. (2007)Comparison of cardiac surgery volumes and mortality rates between the Society of Thoracic Surgeons and Medicare databases from 1993 through 2001. Ann Thorac Surg 84 (5):1538-46. [3] PMID: 17954059
- ↑ Aversano T, Aversano LT, Passamani E, Knatterud GL, Terrin ML, Williams DO, Forman SA (2002). "Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial". JAMA : the Journal of the American Medical Association. 287 (15): 1943–51. PMID 11960536. Retrieved 2011-12-06. Unknown parameter
|month=ignored (help) - ↑ 13.0 13.1 Dehmer GJ, Blankenship J, Wharton TP, Seth A, Morrison DA, Dimario C, Muller D, Kellett M, Uretsky BF (2007). "The current status and future direction of percutaneous coronary intervention without on-site surgical backup: an expert consensus document from the Society for Cardiovascular Angiography and Interventions". Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions. 69 (4): 471–8. doi:10.1002/ccd.21097. PMID 17278155. Retrieved 2011-12-06. Unknown parameter
|month=ignored (help) - ↑ Melberg T, Nilsen DW, Larsen AI, Barvik S, Bonarjee V, Kuiper KK, Nordrehaug JE (2006). "Nonemergent coronary angioplasty without on-site surgical backup: a randomized study evaluating outcomes in low-risk patients". American Heart Journal. 152 (5): 888–95. doi:10.1016/j.ahj.2006.06.026. PMID 17070152. Retrieved 2011-12-06. Unknown parameter
|month=ignored (help) - ↑ Singh PP, Singh M, Bedi US, Adigopula S, Singh S, Kodumuri V, Molnar J, Ahmed A, Arora R, Khosla S (2011). "Outcomes of nonemergent percutaneous coronary intervention with and without on-site surgical backup: a meta-analysis". American Journal of Therapeutics. 18 (2): e22–8. doi:10.1097/MJT.0b013e3181bc0f5a. PMID 19918168. Retrieved 2011-12-06.